KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.502 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $0.202 $0.94
52 weeks $0.202 $3.70

Historical Cerecor Inc. prices

Date Open High Low Close Volume
May 02, 2019 $5.23 $5.44 $5.23 $5.44 34 113
May 01, 2019 $5.45 $5.49 $5.28 $5.31 28 726
Apr 30, 2019 $5.40 $5.49 $5.23 $5.44 26 566
Apr 29, 2019 $5.44 $5.58 $5.26 $5.49 82 610
Apr 26, 2019 $5.60 $5.65 $5.39 $5.49 114 832
Apr 25, 2019 $5.58 $5.78 $5.50 $5.60 73 531
Apr 24, 2019 $5.81 $5.87 $5.58 $5.65 45 897
Apr 23, 2019 $5.74 $5.89 $5.53 $5.82 63 375
Apr 22, 2019 $5.45 $5.85 $5.21 $5.75 205 837
Apr 18, 2019 $5.20 $5.40 $5.12 $5.33 36 045
Apr 17, 2019 $5.19 $5.32 $4.66 $5.20 108 978
Apr 16, 2019 $5.20 $5.27 $5.09 $5.18 38 838
Apr 15, 2019 $5.43 $5.44 $5.11 $5.17 142 185
Apr 12, 2019 $5.66 $5.66 $5.37 $5.44 37 992
Apr 11, 2019 $5.63 $5.74 $5.53 $5.61 44 613
Apr 10, 2019 $5.17 $5.70 $5.17 $5.66 62 751
Apr 09, 2019 $5.41 $5.50 $5.11 $5.15 176 054
Apr 08, 2019 $5.63 $5.80 $5.12 $5.19 128 615
Apr 05, 2019 $5.79 $5.97 $5.63 $5.63 34 664
Apr 04, 2019 $5.70 $6.02 $5.61 $5.80 63 635
Apr 03, 2019 $6.00 $6.23 $5.56 $5.71 129 624
Apr 02, 2019 $6.22 $6.47 $5.90 $5.99 132 302
Apr 01, 2019 $5.90 $6.41 $5.63 $6.22 237 145
Mar 29, 2019 $5.89 $5.89 $5.67 $5.84 142 227
Mar 28, 2019 $5.53 $5.70 $5.40 $5.66 152 940
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT